Table 1.
GHRLOS expression and clinicopathological characteristics of patients with colorectal cancer
Characteristics | Number of case | GHRLOS expression | P value | |
---|---|---|---|---|
Decreased (n=199) Number (%) |
Non-decreased (n=167) Number (%) |
|||
Age | 0.465 | |||
> 65 years | 159 | 83 | 76 | |
≤ 65 years | 207 | 116 | 91 | |
Gender | 0.253 | |||
Male | 196 | 112 | 84 | |
Female | 170 | 87 | 83 | |
Tumor site | 0.930 | |||
Colon | 135 | 73 | 62 | |
Rectum | 231 | 126 | 105 | |
Tumor size | 0.475 | |||
< 5 cm | 214 | 113 | 101 | |
≥ 5 cm | 152 | 86 | 66 | |
Histological subtype | 0.281 | |||
Adenocarcinoma | 341 | 188 | 153 | |
Others | 25 | 11 | 14 | |
Histological grade | 0.079 | |||
Well/Moderate | 271 | 140 | 131 | |
Poor | 95 | 59 | 36 | |
Depth of tumor invasion | 0.074 | |||
T1+T2 | 110 | 52 | 58 | |
T3+T4 | 256 | 147 | 109 | |
Lymph node metastasis | 0.033 | |||
Absence | 217 | 108 | 109 | |
Presence | 149 | 91 | 58 | |
Distant metastasis | 0.005 | |||
Absence | 315 | 162 | 153 | |
Presence | 51 | 37 | 14 | |
Serum CEA level | 0.136 | |||
≥ 10 ng/mL | 268 | 152 | 116 | |
< 10 ng/mL | 98 | 47 | 51 |
CEA, carcinoembryonic antigen.